Germany
· Delayed Price · Currency is EUR Merck KGaA Statistics
Total Valuation
Merck KGaA has a market cap or net worth of EUR 48.74 billion. The enterprise value is 55.89 billion.
| Market Cap | 48.74B |
| Enterprise Value | 55.89B |
Important Dates
The next estimated earnings date is Thursday, August 7, 2025.
| Earnings Date | Aug 7, 2025 |
| Ex-Dividend Date | Apr 28, 2025 |
Share Statistics
Merck KGaA has 434.78 million shares outstanding. The number of shares has increased by 0.14% in one year.
| Current Share Class | 129.24M |
| Shares Outstanding | 434.78M |
| Shares Change (YoY) | +0.14% |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 16.01% |
| Float | 129.20M |
Valuation Ratios
The trailing PE ratio is 17.31 and the forward PE ratio is 12.54. Merck KGaA's PEG ratio is 2.23.
| PE Ratio | 17.31 |
| Forward PE | 12.54 |
| PS Ratio | 2.29 |
| PB Ratio | 1.63 |
| P/TBV Ratio | 9.25 |
| P/FCF Ratio | 19.97 |
| P/OCF Ratio | 11.87 |
| PEG Ratio | 2.23 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.51, with an EV/FCF ratio of 22.90.
| EV / Earnings | 19.83 |
| EV / Sales | 2.62 |
| EV / EBITDA | 9.51 |
| EV / EBIT | 13.43 |
| EV / FCF | 22.90 |
Financial Position
The company has a current ratio of 1.31, with a Debt / Equity ratio of 0.29.
| Current Ratio | 1.31 |
| Quick Ratio | 0.69 |
| Debt / Equity | 0.29 |
| Debt / EBITDA | 1.48 |
| Debt / FCF | 3.56 |
| Interest Coverage | 17.86 |
Financial Efficiency
Return on equity (ROE) is 9.75% and return on invested capital (ROIC) is 6.79%.
| Return on Equity (ROE) | 9.75% |
| Return on Assets (ROA) | 5.26% |
| Return on Invested Capital (ROIC) | 6.79% |
| Return on Capital Employed (ROCE) | 10.44% |
| Revenue Per Employee | 340,489 |
| Profits Per Employee | 45,013 |
| Employee Count | 59,020 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 1.88 |
Taxes
In the past 12 months, Merck KGaA has paid 769.00 million in taxes.
| Income Tax | 769.00M |
| Effective Tax Rate | 21.40% |
Stock Price Statistics
The stock price has decreased by -34.83% in the last 52 weeks. The beta is 0.64, so Merck KGaA's price volatility has been lower than the market average.
| Beta (5Y) | 0.64 |
| 52-Week Price Change | -34.83% |
| 50-Day Moving Average | 117.76 |
| 200-Day Moving Average | 139.17 |
| Relative Strength Index (RSI) | 35.27 |
| Average Volume (20 Days) | 309,665 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Merck KGaA had revenue of EUR 21.32 billion and earned 2.82 billion in profits. Earnings per share was 6.48.
| Revenue | 21.32B |
| Gross Profit | 12.66B |
| Operating Income | 4.16B |
| Pretax Income | 3.59B |
| Net Income | 2.82B |
| EBITDA | 5.88B |
| EBIT | 4.16B |
| Earnings Per Share (EPS) | 6.48 |
Balance Sheet
The company has 1.62 billion in cash and 8.70 billion in debt, giving a net cash position of -7.08 billion or -16.28 per share.
| Cash & Cash Equivalents | 1.62B |
| Total Debt | 8.70B |
| Net Cash | -7.08B |
| Net Cash Per Share | -16.28 |
| Equity (Book Value) | 29.90B |
| Book Value Per Share | 68.57 |
| Working Capital | 2.91B |
Cash Flow
In the last 12 months, operating cash flow was 4.11 billion and capital expenditures -1.67 billion, giving a free cash flow of 2.44 billion.
| Operating Cash Flow | 4.11B |
| Capital Expenditures | -1.67B |
| Free Cash Flow | 2.44B |
| FCF Per Share | 5.61 |
Margins
Gross margin is 59.39%, with operating and profit margins of 19.53% and 13.22%.
| Gross Margin | 59.39% |
| Operating Margin | 19.53% |
| Pretax Margin | 16.86% |
| Profit Margin | 13.22% |
| EBITDA Margin | 27.57% |
| EBIT Margin | 19.53% |
| FCF Margin | 11.45% |
Dividends & Yields
This stock pays an annual dividend of 2.20, which amounts to a dividend yield of 1.92%.
| Dividend Per Share | 2.20 |
| Dividend Yield | 1.92% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 36.37% |
| Buyback Yield | -0.14% |
| Shareholder Yield | 1.78% |
| Earnings Yield | 5.78% |
| FCF Yield | 5.01% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 30, 2014. It was a forward split with a ratio of 2.
| Last Split Date | Jun 30, 2014 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Merck KGaA has an Altman Z-Score of 3.48 and a Piotroski F-Score of 8.
| Altman Z-Score | 3.48 |
| Piotroski F-Score | 8 |